Sign In
Buy AVEO
$15.00
+0 (+0%)
At Close: Apr 18, 2023
6 Stock Charts To Watch: AMRN, DAL, LSCC, PENN, SM, UAVS
12:00am, Thursday, 30'th Apr 2020
Stocks Analysis by Harry Boxer covering: Alcoa Corp, Occidental Petroleum Corporation, Apache Corporation, Valero Energy Corporation. Read Harry Boxer's latest article on Investing.com
AVEO Oncology (NASDAQ: AVEO) today announced that the final overall survival analysis from its pivotal Phase 3 TIVO-3 trial comparing tivozanib, AVEO’s vascular endothelial growth factor receptor ty
AVEO (AVEO) Up 39.9% Since Last Earnings Report: Can It Continue?
12:00am, Wednesday, 15'th Apr 202054 Stocks Moving In Wednesday's Mid-Day Session
04:30pm, Wednesday, 01'st Apr 2020
Gainers
InflaRx N.V. (NASDAQ: IFRX) shares jumped 56.8% to $5.99 after the company said it has enrolled and dosed the first patient into a randomized clinical trial...
31 Stocks Moving in Wednesday's Pre-Market Session
11:18am, Wednesday, 01'st Apr 2020
Gainers
InflaRx N.V. (NASDAQ: IFRX) shares rose 133% to $8.90 in pre-market trading after the company announced it dosed the first patient in a clinical study with IFX-1 in...
Piper Sandler Reiterates Overweight on AVEO Pharmaceuticals, Lowers Price Target to $18.5
12:00am, Wednesday, 01'st Apr 20206 Stocks Moving In Tuesday's After-Hours Session
08:39pm, Tuesday, 31'st Mar 2020
Gainers
AVEO Pharmaceuticals (NASDAQ: AVEO) shares are trading higher after the company announced the submission of a new drug application to the FDA for Tivozanib in...
AVEO Oncology (NASDAQ: AVEO) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tivozanib, the Company’s vascular endothelial growt
AVEO Stops AML Study on Ficlatuzumab Amid Coronavirus Pandemic
03:54pm, Monday, 30'th Mar 2020
AVEO ceases the phase II CyFi-2 study on ficlatuzumab plus high-dose cytarabine for treating patients with relapsed/refractory acute myeloid leukemia to combat the COVID-19 outbreak.
Bristol-Myers' Ozanimod Approval, And Other News: The Good, Bad And Ugly Of Biopharma
09:39am, Monday, 30'th Mar 2020
Bristol-Myers Squibb received US approval for ozanimod, the MS drug it acquired through Celgene. Rockwell also got an approval for Triferic. Aveo is discontinui
AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced the discontinuation of their CyFi-2 study, a randomized Phase 2 clinical study evaluating ficlatuzumab, AVEO’s potent hepatocyte growt
90 Biggest Movers From Yesterday
08:01am, Friday, 27'th Mar 2020
Gainers
Granite Point Mortgage Trust Inc. (NYSE: GPMT) shares jumped 202.7% to close at $6.81 on Thursday. JMP Securities upgraded Granite Point Mortgage from Market Perform to...
60 Stocks Moving In Thursday's Mid-Day Session
04:33pm, Thursday, 26'th Mar 2020
Gainers
Granite Point Mortgage Trust Inc. (NYSE: GPMT) shares climbed 214.7% to $7.08. JMP Securities upgraded Granite Point Mortgage from Market Perform to Market Outperform...
